BGI, Imperial College, Waters Ink Deal to Accelerate Translational Medicine | GenomeWeb

NEW YORK (GenomeWeb) – BGI, Imperial College of London, and Waters today signed a framework agreement to accelerate translational medicine.

Through R&D projects incorporating omics-related and clinical applications, the partners plan to develop comprehensive standards and approaches for human omics testing and data analysis, BGI said. Work will focus on biomarker detection, as well as the integration of multidimensional data and information from 3D imaging, for example, in order to translate, accumulate, and update omics, clinical, and health knowledge.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.